News

Asianet Newsable on MSN14h
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability
Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700.
Editas Medicine: Primed For An Unlikely Comeback? It's Not Impossible
Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...
Stock market today: Dow, S&P 500, Nasdaq mixed as Fed holds rates, Powell says 'no decisions' on September
Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.
Stockhead on MSN13h
ASX Health Quarterly Wrap: Neurizon turns up the dial on ALS drug progress
The latest quarterly reporting season is underway, with investors tuning in to see how ASX-listed companies performed during ...
Stock market today: Dow, S&P 500, Nasdaq steady as Wall Street awaits Fed decision, Big Tech results
Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.
Stock market today: Dow, S&P 500, Nasdaq rise as Fed holds rates steady, Big Tech results loom
Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.